Financial Data and Key Metrics Changes - For Q3 2025, total revenue was approximately $1 billion, a 7% sequential increase, exceeding expectations by about $65 million [6][12] - Adjusted EBITDA margin for Q3 was 17.1%, exceeding expectations by approximately 140 basis points [6][12] - GAAP EPS for Q3 was $1.28, while adjusted EPS was $1.94, excluding certain one-time items [8][12] - The company raised its full-year 2025 revenue guidance to between $3.76 billion and $3.79 billion, reflecting strong Q3 results [12][13] Business Line Data and Key Metrics Changes - JBT segment revenue was $465 million, a 2% increase year-over-year and sequentially, with adjusted EBITDA of $71 million, a 13% decrease [10][11] - Marel segment revenue was $537 million, a 12% sequential increase, with adjusted EBITDA of $100 million and a margin of 18.6% [11] - Year-over-year synergy savings for Q3 amounted to $14 million, contributing to improved margins [7][12] Market Data and Key Metrics Changes - Combined JBT/Marel orders totaled $946 million, a 7% increase from the prior year, with strong demand in the poultry industry [3][4] - North America showed strong demand, while Europe and Asia were softer sequentially; Latin America had a good quarter with large orders [4][12] - The company ended Q3 with a backlog of $1.3 billion, providing visibility for the remainder of the year [4][12] Company Strategy and Development Direction - The integration of JBT and Marel is on track, focusing on capturing synergy savings and enhancing customer value [4][12] - New segment reporting will be introduced in Q4, dividing operations into Protein Solutions and Prepared Food and Beverage Solutions [10][12] - The company aims to achieve annual run rate savings of $150 million within three years of the combination [13] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ongoing demand in the poultry market and anticipated continued investment in related projects [3][39] - The company expects to see a ramp in tariff expenses impacting margins in Q4, but remains optimistic about overall demand [8][29] - Visibility into 2026 revenue is strong, with expectations for growth supported by a healthy backlog and order pipeline [42][43] Other Important Information - The company made significant progress on deleveraging its balance sheet, reducing the leverage ratio from four times to 3.1 times by the end of Q3 [12] - A new global production center was inaugurated in Pune, India, enhancing the company's manufacturing capabilities in the Asia-Pacific region [16][18] - Sustainability remains a core focus, with the publication of the first joint sustainability report highlighting efforts to minimize waste and improve food safety [17][18] Q&A Session Summary Question: What is driving the high EBITDA margin in the Marel segment? - Management highlighted strong volume throughput and operating leverage as key factors, along with a higher share of synergies and improved technology [25][26] Question: What are the expectations for Q4 revenue and cost impacts? - Management expects lower revenue in Q4 compared to Q3 due to a one-time boost in Q3 from backlog clearance and anticipates increased tariff expenses impacting margins [28][29] Question: How is automation trending in the business? - Automation remains a key focus, particularly in the protein sector, with significant opportunities in secondary processing areas [31] Question: Can you provide insights on cross-selling opportunities? - Management noted improvements in cross-selling opportunities, with successful integration of JBT and Marel portfolios leading to stronger pipeline development [33][36] Question: What is the outlook for the AGV business? - The AGV business is expected to see strong demand moving into Q4 and 2026, despite a weaker performance in Q3 due to tariffs and delayed orders [52] Question: How is the company managing tariff impacts on pricing? - The company has enacted price increases to mitigate tariff impacts and has maintained strong order levels, indicating effective management of customer relationships [47][53]

Financial Data and Key Metrics Changes - In Q3 2025, total revenue was approximately $1,000,000,000, representing a 7% sequential increase and exceeding expectations by about $65,000,000 [5][8] - Adjusted EBITDA margin for Q3 was 17.1%, exceeding expectations by approximately 140 basis points [9] - GAAP EPS for Q3 was $1.28, while adjusted EPS was $1.94, excluding certain one-time items [10] - The company raised its full-year 2025 revenue guidance to between $3,760,000,000 and $3,790,000, reflecting strong Q3 results [15] Business Line Data and Key Metrics Changes - JBT segment revenue was $465,000,000, increasing approximately 2% year-over-year and sequentially, with adjusted EBITDA of $71,000,000, a decrease of 13% [13] - MREL segment revenue was $537,000,000, a 12% sequential increase, with adjusted EBITDA of $100,000,000 and a margin of 18.6% [13][14] - Year-over-year synergy savings for Q3 amounted to $14,000,000 [10] Market Data and Key Metrics Changes - Combined JBT Madau orders reached $946,000,000, a 7% increase from the prior year [5] - Demand was strong in North America, while Europe and Asia showed softer performance; however, Latin America had a good quarter with large orders in pet food, poultry, and juice [6] Company Strategy and Development Direction - The company plans to introduce new segment reporting for 2025, focusing on Protein Solutions and Prepared Food and Beverage Solutions [12] - The integration of JBT and Morel is on track, with actions taken to capture synergy savings and enhance customer value [7][18] - The company aims to achieve annual run rate savings of $150,000,000 within three years of the combination [15] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the strong demand environment, particularly in the poultry market, with visibility extending into 2026 [49][61] - The company anticipates a growth year in 2026, supported by a strong backlog and healthy demand [59][61] - Management highlighted the importance of automation in response to labor pressures in food factories, particularly in the protein sector [37] Other Important Information - The company generated operating cash flow of $224,000,000 and free cash flow of $163,000,000 for the year, with record quarterly operating cash flow of $88,000,000 in Q3 [14] - The financial leverage ratio decreased from four times at the close of the combination to 3.1 times by the end of Q3, with expectations to drop below three times by year-end [14][15] Q&A Session Summary Question: What is driving the higher EBITDA margins in the Morrel segment? - Management attributed the higher margins to increased volume, operating leverage, and synergy savings, along with improvements in meat and fish segments [30] Question: What are the expectations for Q4 in terms of revenue and costs? - Management expects lower revenue in Q4 compared to Q3 due to a pickup in Q3 that is not expected to recur, along with anticipated increases in tariff expenses impacting margins [33][35] Question: How is automation trending in the business? - Automation remains a key focus, particularly in the protein sector, with significant opportunities in secondary processing areas [37] Question: Can you provide insights on cross-selling opportunities? - Management noted improvements in cross-selling opportunities, with a strong pipeline and successful integration of sales teams from both legacy companies [42][48] Question: What is the outlook for the AGV business? - The AGV business is expected to see strong demand moving into Q4 and 2026, despite a weaker performance in Q3 due to tariffs and delayed orders [76] Question: How is the company managing tariff impacts and pricing? - The company has enacted price increases to mitigate tariff impacts and has been fair with customers, resulting in strong order retention [78]

Financial Data and Key Metrics Changes - The company reported net revenue of $36.2 million for Q3 2025, a record high, representing a $1.2 million or 3.3% increase from the prior year [12] - Gross profit reached $20.8 million, also a record, with a 9.3% increase over the prior year [14] - Adjusted EBITDA for Q3 2025 was $8.3 million, reflecting a 5.6% increase from the previous year [15] - The net debt decreased by $5.7 million during the third quarter, despite stock repurchases totaling $2.2 million [17] Business Line Data and Key Metrics Changes - Patient Services net revenue increased by $1.6 million or 7.6%, driven by higher treatment volumes in oncology and wound care [13] - Oncology revenue increased by nearly $700,000 or 3.6%, while wound care revenue surged by 116% to $2 million, primarily due to volume increases from partnerships and acquisitions [13] - Device Solutions net revenue decreased by $400,000 or 2.9%, mainly due to lower revenue in biomedical services [13] Market Data and Key Metrics Changes - The company secured a significant new contract with a large hospital system for its oncology business, contributing to increased market share [9] - A multiyear contract extension with a national insurance payer was secured, providing enhanced service coverage and a price increase [10] Company Strategy and Development Direction - The company is focusing on leveraging strategic competencies in its Patient Solutions segment, particularly in wound care, to lower processing costs and improve efficiency [5] - The integration of the Apollo acquisition is aimed at streamlining billing processes and enhancing operational efficiency [5] - The company is committed to executing profitable growth and driving long-term value creation for shareholders [20] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to maintain revenue growth between 6% to 8% and an adjusted EBITDA margin of 20% or greater for the full year [20] - The management acknowledged challenges in the Biomedical Services segment but emphasized the importance of profitability as a key driver of shareholder value [11] Other Important Information - The company is implementing AI and automation enhancements to improve efficiency in its operations [6] - A contract amendment with the largest Biomedical Services customer is expected to reduce revenue by $6 million to $7 million annually but will improve operating income by reducing costs [11] Q&A Session Summary Question: Can you talk about enhancements in the wound care business? - Management highlighted the successful implementation of a new revenue cycle system that incorporates AI and automation, leading to improved efficiency [25][26] Question: What is the impact of the biomedical service contract changes? - The revenue from the contract is expected to decrease by 40%, but the new structure will improve profitability significantly [28][30] Question: How do you balance margin improvement with revenue momentum? - The focus is on correcting areas with lower margins and prioritizing growth in segments that require less capital investment [38] Question: Are there additional opportunities in oncology? - Management indicated ongoing focus on wound care and patient services, with potential for growth in these areas [41] Question: What are the expected impacts of the ERP expenses? - ERP expenses will taper off significantly in 2026, but some maintenance costs will remain [48] Question: Will there be one-time expenses related to the contract transition? - There will be some low, manageable costs associated with reallocating team members [62]

Core Insights - The forum highlighted that China's industrial upgrade is shifting from merely addressing shortcomings to a comprehensive system reconstruction, creating numerous investment opportunities in automation, green technology, and intelligence [1][24][30] Group 1: Investment Opportunities - The focus areas for investment include automation, where China has developed competitive advantages, particularly in motor product exports [6][10] - Green technology is emphasized as a long-term focus, despite current supply-demand imbalances in the renewable energy sector [6][10] - The intelligence sector is witnessing significant growth in demand for technology and new components, indicating a long-term trend for investment [6][10] Group 2: Market Dynamics - The Chinese market is characterized by a significant unmet consumer demand, which is a key area for future investment [7][10] - The Hong Kong stock market has shown positive performance, with increased IPO activity and a complex investor structure, indicating a favorable investment environment [10][12] - The overall sentiment in the market is cautious yet optimistic, with a focus on cash flow and policy certainty [24][30] Group 3: Global Expansion - Chinese companies are increasingly looking to expand overseas, with a focus on integrating into local markets and building brand recognition [12][14] - The shift in China's outward direct investment (ODI) is moving from infrastructure and raw materials to technology, brand, and high-end manufacturing [25][26] - The importance of local integration and building ecosystems is highlighted as critical for successful overseas expansion [14][20] Group 4: Sector-Specific Insights - The technology sector is identified as a key area for future investment, with a focus on companies that continuously invest in R&D and possess core technological advantages [30][31] - The cultural and entertainment industries are also seen as promising for overseas expansion, leveraging mature IP operations and user management capabilities [30][31] - The advanced manufacturing and AI application sectors are noted for their resilience and global competitiveness, providing unique investment opportunities [31][34]

Core Viewpoint - The article discusses the transformation of China's industrial upgrade from merely filling gaps to a comprehensive system reconstruction, creating numerous investment opportunities in automation, greening, and intelligence within the manufacturing sector [2][32]. Group 1: Investment Opportunities - The focus is on three key areas for investment: automation, green production, and intelligence. Automation has shown a competitive advantage in China's manufacturing, with motor product exports growing faster than overall exports by about 2 percentage points [8]. - Green production is emphasized as a long-term focus, despite current supply-demand imbalances in the renewable energy sector, with potential for mean reversion through supportive policies [9]. - The intelligence sector is highlighted as a long-term trend, with significant growth in demand for technology and new components, although many industries are still in the exploratory phase [9]. Group 2: Market Dynamics - The article notes a significant divergence in market performance, with new economy sectors outperforming traditional ones, reinforcing the investment logic based on industrial upgrades [8]. - The Hong Kong stock market has seen increased activity, particularly in IPOs, with a complex investor structure that includes both long-term and trading strategies [13]. Group 3: Global Expansion - The article emphasizes the importance of understanding local markets for Chinese companies looking to expand internationally. Successful overseas ventures require local market experience and a sound value system [8][20]. - The shift from traditional exports to global operations is noted, with a focus on brand building, ecosystem development, and localization as key barriers to entry in foreign markets [21][20]. Group 4: Industry Insights - The article highlights the systemic advantages of Chinese manufacturing, particularly in new energy, electric vehicles, and AI, where Chinese companies are rapidly advancing [14][11]. - The need for companies to integrate into local ecosystems and achieve "common prosperity" is stressed, as many firms face challenges in local market integration [28][26]. Group 5: Economic Outlook - The article presents a cautiously optimistic view of the Chinese market, with signs of recovery and a shift towards a more rational investment approach focusing on cash flow and policy certainty [31]. - The transition from a follow-up model to a systematic reconstruction of the industry is seen as a significant historical shift, supported by China's talent pool and innovation capabilities [34][32]. Group 6: Future Trends - The article identifies three trends for future investment: industrial collaboration, diversification of overseas markets, and enhanced risk management capabilities [35]. - It also points to the importance of focusing on hidden champions in the industry, specialized consumer products, and new infrastructure opportunities in green and digital sectors [35]. Group 7: Technology Focus - The article underscores the critical role of technology in future investments, particularly in advanced manufacturing, AI applications, and the development of a robust talent ecosystem [44]. - It emphasizes the need for long-term value and global scarcity in technology investments, advocating for a deep understanding of industry dynamics to capture growth opportunities [44].

Group 1 - The 2025 Nobel Prize in Economic Sciences was awarded to Joel Mokyr, Philippe Aghion, and Peter Howitt for their contributions to understanding innovation-driven economic growth [3] - Philippe Aghion's work emphasizes the central role of innovation in economic development, highlighting the dual nature of technological revolutions as both a threat and an opportunity [3] - The article discusses the characteristics of general-purpose technologies, which include the generation of secondary innovations, gradual cost improvements, and widespread diffusion across economic sectors [4] Group 2 - Secondary innovations are crucial for adapting general-purpose technologies to specific sectors, leading to productivity improvements and long-term growth, although they may initially slow GDP growth [5] - There are instances where society may not optimally adopt new technologies due to a lack of secondary innovations or widespread acceptance, leading to the persistence of suboptimal standards [6] - The adoption of new general-purpose technologies requires time for users to learn efficient usage, which can lead to price reductions for older technology as newer versions become more efficient [7] Group 3 - Households exhibit similar delays in adopting new technologies as businesses, primarily influenced by price declines [8] - Delays in the spread of technological waves, such as the electricity revolution, can be attributed to infrastructure and institutional deficiencies in other countries [9] - Measuring productivity gains from new general-purpose technologies can be challenging, particularly in the service sector, where improvements may not be well reflected in productivity statistics [10] Group 4 - Automation and artificial intelligence are increasingly impacting production activities, yet the expected surge in growth rates in developed countries has not materialized, possibly due to the continued necessity of labor in key processes [11] - Historical perspectives reveal that fears of job loss due to automation have existed for centuries, but technological advancements have often led to positive employment outcomes [12] - Studies indicate that increased automation in factories correlates with job creation, particularly in non-skilled manufacturing roles, challenging the notion that automation solely destroys jobs [12][13] Group 5 - Industries with higher levels of automation tend to experience job growth, suggesting a positive relationship between automation and employment [13] - Measures to slow down automation, such as taxing robots, may hinder productivity and innovation, ultimately harming job creation [14] - The article concludes that while technological revolutions may initially present challenges, they do not necessarily lead to widespread unemployment and can create net job gains in automated environments [15]

Core Viewpoint - Honeywell is restructuring its business segments in preparation for the planned spin-offs of its Solstice Advanced Materials and Aerospace Technology businesses, with the latter expected to be completed in the second half of 2026 [1][6]. Business Segment Updates - The Solstice Advanced Materials business was successfully spun off on October 30, 2025, while the Aerospace Technology business will be reported as a separate entity starting from the first quarter of 2026 [1][6]. - Following the spin-off, Honeywell will report its performance across four main business segments: Aerospace Technology, Smart Building Technology, Smart Industrial Technology, and Process Automation and Technology, effective January 1, 2026 [1][3]. Aerospace Business Spin-off - The Aerospace business, once spun off, will become one of the largest independent publicly traded aerospace suppliers, leveraging its technological and systems advantages to enhance flight electrification and autonomy [1][2]. - Honeywell's aerospace technologies are integrated into nearly every commercial aircraft globally, including propulsion systems, cockpit and navigation systems, and auxiliary power systems [1]. Strategic Focus Post Spin-off - Post spin-off, Honeywell aims to lead the industrial sector's transition from automation to autonomy, utilizing a comprehensive portfolio of technology, solutions, and software to enhance customer productivity [3]. - The company emphasizes the importance of data utilization from its extensive global customer base to address complex challenges across various sectors, including building and industrial facilities [3]. Leadership Structure - The leadership for the new business segments will include Billal Hammoud as President and CEO of Smart Building Technology, Peter Lau as President and CEO of Smart Industrial Technology, and Jim Masso as President and CEO of Process Automation [5].

Financial Data and Key Metrics Changes - In Q3 2025, the company achieved 5% organic growth, with adjusted EPS of $3.07, reflecting an 11% year-over-year increase [4][15] - Adjusted operating margin expanded by 230 basis points year-over-year to 20% [15][26] - Free cash flow for the nine months ending September 30, 2025, was $838 million, an increase of $114 million from the prior year [28] Business Line Data and Key Metrics Changes - Health, Wealth & Career (HWC) revenue grew 4% year-over-year, with 5% growth when excluding book of business settlement activity and interest income [16][20] - The Health segment achieved 7% growth, or 8% excluding certain impacts, driven by strong performance in International and North America [17] - Risk and Broking (R&B) reported 6% organic growth, marking the 11th consecutive quarter of high single-digit growth when excluding specific impacts [8][21] Market Data and Key Metrics Changes - The company noted headwinds from declining rates in certain segments of the commercial insurance market across various geographies [6][22] - Pricing pressure was particularly noted in property insurance, with most lines showing softening except for North American Casualty, where pricing continues to rise [42][81] Company Strategy and Development Direction - The company continues to focus on its specialization strategy, investments in talent, data, and technology to drive sustainable growth [21][60] - The strategy aims to enhance efficiency and optimize the portfolio, which has been effective despite macroeconomic volatility [5][29] - The company is committed to delivering 100 basis points of average annual adjusted operating margin expansion over the next three years [24][37] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving mid-single-digit organic growth and margin expansion for 2025, despite challenges in the current pricing environment [29][60] - The company anticipates strong demand across its global business driven by healthcare inflation and employers' focus on managing costs [17][68] Other Important Information - The divestiture of TRANZACT is expected to create a headwind to adjusted diluted earnings per share of $1.14 for the full year 2025 [15] - The company returned $690 million to shareholders via share repurchases and dividends during the quarter [28] Q&A Session Summary Question: Insights on Risk and Broking organic revenue results - Management noted that the 6% growth in Risk and Broking was supported by strong new business across global markets and specialty lines, with project-based placements contributing to growth [31][34] Question: Concerns about margin expansion in Risk and Broking - Management reaffirmed commitment to achieving 100 basis points of margin improvement annually, driven by technology investments and process improvements [36][37] Question: Expectations for free cash flow in the fourth quarter - Management indicated confidence in delivering free cash flow margin expansion, supported by reduced transformation costs and the divestiture of TRANZACT [39][40] Question: Impact of insurance pricing headwinds - Management acknowledged ongoing pricing pressure, particularly in property insurance, but maintained expectations for mid to high single-digit organic revenue growth in Risk and Broking [42][43] Question: HWC margins and future outlook - Management highlighted consistent margin improvement in HWC, driven by disciplined resource management and process optimization [45][46] Question: Prospects for BD&O growth - Management expressed confidence in BD&O growth due to the timing of revenue generation, particularly during the Medicare enrollment period [48][49] Question: Talent acquisition and retention - Management emphasized the company's ability to attract and retain top talent, which is crucial for driving organic growth [54][56]

Financial Data and Key Metrics Changes - In Q3 2025, the company achieved 5% organic growth and expanded adjusted operating margin by 230 basis points to 20% [15][20] - Adjusted EPS was $3.07, reflecting an 11% year-over-year increase [3][15] - Free cash flow for the nine months ending September 30, 2025, was $838 million, an increase of $114 million from the prior year [26][28] Business Line Data and Key Metrics Changes - Health, Wealth & Career (HWC) revenue grew 4% year-over-year, with 5% growth when excluding book of business settlement activity and interest income [16][20] - The Health segment achieved 7% growth, driven by strong performance in International and North America [17][20] - Risk and Broking (R&B) reported 6% organic growth, with Corporate Risk & Broking (CRB) growing 6% or 7% when excluding book of business activity and interest income [21][24] Market Data and Key Metrics Changes - The company noted headwinds from declining rates in certain segments of the commercial insurance market across various geographies [4][22] - Pricing pressure has continued in certain areas, particularly in property insurance, but the company expects mid to high single-digit organic revenue growth in Risk and Broking despite these challenges [42][76] Company Strategy and Development Direction - The company is focused on accelerating performance, enhancing efficiency, and optimizing its portfolio to drive value for stakeholders [4][29] - Investments in digital tools, AI, and automation are seen as key to capturing growth opportunities and creating efficiencies [8][29] - The company aims for 100 basis points of average annual adjusted operating margin expansion over the next three years [24][29] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in delivering on 2025 financial objectives, including mid-single-digit organic growth and adjusted operating margin expansion [29] - The macroeconomic environment presents both opportunities and challenges, with concerns about global trade, inflation, and geopolitical conditions [4][29] - The company anticipates strong demand across its global business driven by healthcare inflation and employers' focus on managing costs [17][29] Other Important Information - The company returned $690 million to shareholders through share repurchases and dividends [28] - The divestiture of TRANZACT is expected to create a headwind to adjusted diluted earnings per share of $1.14 for the full year 2025 [15][26] Q&A Session Summary Question: Insights on Risk and Broking organic revenue results - Management noted that the 6% growth in R&B was supported by strong new business across global markets and specialty lines, with project-based placements contributing to growth [31][35] Question: Expectations for free cash flow - The company confirmed confidence in delivering free cash flow margin expansion, driven by operating margin improvements and reduced transformation costs [39][41] Question: Insurance pricing headwinds - Management indicated that pricing pressure is most significant in property insurance, but they expect mid to high single-digit organic revenue growth in Risk and Broking despite these developments [42][43] Question: HWC margins and future expectations - Management reiterated commitment to incremental margin improvement in HWC, with a focus on process optimization and resource management [45][49] Question: BD&O business growth expectations - The company expects BD&O to generate nearly half of its revenue in the fourth quarter, driven by new client implementations and the timing of commissions [51][52] Question: Interest income levels - Management clarified that interest income levels are influenced by geographic cash balances and interest rates, with no specific one-time factors affecting current results [54][55]

Financial Data and Key Metrics Changes - AMETEK reported record sales of $1.89 billion, an increase of 11% from Q3 2024 [5] - Organic sales grew by 4%, acquisitions contributed 6 points, and foreign currency translation added 1 point [6] - Operating income reached a record $496 million, up 11% year-over-year, with EBITDA at $592 million, also up 11% [7][19] - Diluted earnings per share increased by 14% to $1.89 compared to Q3 2024 [7] Business Line Data and Key Metrics Changes - The Electronic Instruments Group (EIG) achieved sales of $1.25 billion, a 10% increase, with operating income of $360 million, up 6% [8] - The Electromechanical Group (EMG) saw sales of $646 million, up 13%, with operating income rising 25% to $164 million [9] Market Data and Key Metrics Changes - Overall orders increased by 13% to a record $1.97 billion, with a backlog of $3.54 billion [6] - Sales in the U.S. were up mid-single digits, while international sales increased low single digits, with Europe showing low double-digit growth [34][35] Company Strategy and Development Direction - AMETEK is focusing on strategic acquisitions as a core element of its growth strategy, with an incremental $90 million planned for organic growth initiatives in 2025 [11] - The company is leveraging its operational excellence and global infrastructure to adapt to changing market dynamics [10][18] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the automation and engineered solutions markets, despite macroeconomic uncertainties [9][10] - The company anticipates full-year sales growth in the mid-single digits and has raised its earnings guidance for the year [16][17] Other Important Information - AMETEK's effective tax rate decreased to 17.2%, down from 18.8% in Q3 2024, with capital expenditures expected to be around $150 million for the year [20][21] - The company maintains significant financial flexibility with over $2 billion in cash and available credit [22] Q&A Session Summary Question: Insights on key platforms and regions - Management highlighted strong performance in the process market segment and noted that trade uncertainty is causing slower decision-making [31] Question: Comments on tariffs and their impact - Management indicated that tariff renegotiations are causing delays in China, but they remain confident in long-term prospects [36] Question: Update on Paragon's performance - Paragon showed strong double-digit order growth, and management is optimistic about its future profitability [44] Question: Outlook for the process industry - Management noted that process orders are trending up, with expectations for a strong 2026 [72] Question: Update on M&A pipeline - The M&A pipeline remains strong, with active pursuit of high-quality deals across various end markets [114]